Clinical Applications of Photon-counting CT: A Review of Pioneer Studies and a Glimpse into the Future.


Journal

Radiology
ISSN: 1527-1315
Titre abrégé: Radiology
Pays: United States
ID NLM: 0401260

Informations de publication

Date de publication:
10 2023
Historique:
pmc-release: 01 10 2024
medline: 4 10 2023
pubmed: 3 10 2023
entrez: 3 10 2023
Statut: ppublish

Résumé

CT systems equipped with photon-counting detectors (PCDs), referred to as photon-counting CT (PCCT), are beginning to change imaging in several subspecialties, such as cardiac, vascular, thoracic, and musculoskeletal radiology. Evidence has been building in the literature underpinning the many advantages of PCCT for different clinical applications. These benefits derive from the distinct features of PCDs, which are made of semiconductor materials capable of converting photons directly into electric signal. PCCT advancements include, among the most important, improved spatial resolution, noise reduction, and spectral properties. PCCT spatial resolution on the order of 0.25 mm allows for the improved visualization of small structures (eg, small vessels, arterial walls, distal bronchi, and bone trabeculations) and their pathologies, as well as the identification of previously undetectable anomalies. In addition, blooming artifacts from calcifications, stents, and other dense structures are reduced. The benefits of the spectral capabilities of PCCT are broad and include reducing radiation and contrast material dose for patients. In addition, multiple types of information can be extracted from a single data set (ie, multiparametric imaging), including quantitative data often regarded as surrogates of functional information (eg, lung perfusion). PCCT also allows for a novel type of CT imaging, K-edge imaging. This technique, combined with new contrast materials specifically designed for this modality, opens the door to new applications for imaging in the future.

Identifiants

pubmed: 37787672
doi: 10.1148/radiol.222432
pmc: PMC10623209
doi:

Substances chimiques

Contrast Media 0

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e222432

Subventions

Organisme : NIBIB NIH HHS
ID : R21 EB030373
Pays : United States

Informations de copyright

© RSNA, 2023.

Références

J Cardiovasc Comput Tomogr. 2020 Jan - Feb;14(1):68-74
pubmed: 31416723
Osteoporos Int. 2021 Aug;32(8):1465-1485
pubmed: 34023944
Invest Radiol. 2022 Aug 1;57(8):536-543
pubmed: 35318969
PLoS One. 2021 Mar 5;16(3):e0247355
pubmed: 33667250
Nanoscale. 2017 Nov 30;9(46):18246-18257
pubmed: 28726968
Eur Radiol. 2022 Jan;32(1):152-162
pubmed: 34255159
Sci Rep. 2018 Aug 14;8(1):12119
pubmed: 30108247
Invest Radiol. 2020 Feb;55(2):61-67
pubmed: 31524765
Radiology. 2022 May;303(2):303-313
pubmed: 35166583
Diagn Interv Imaging. 2023 Feb;104(2):51-52
pubmed: 36428159
Radiology. 2017 Dec;285(3):980-989
pubmed: 28753389
Proc SPIE Int Soc Opt Eng. 2017 Feb 11;10132:
pubmed: 28392613
Sci Rep. 2019 Aug 20;9(1):12090
pubmed: 31431689
Sci Rep. 2018 Nov 26;8(1):17386
pubmed: 30478300
Br J Radiol. 2019 Jan;92(1093):20180226
pubmed: 30048155
Diagn Interv Imaging. 2021 May;102(5):305-312
pubmed: 33610503
Radiology. 2023 Apr;307(1):e222087
pubmed: 36445225
Eur Radiol. 2022 Jan;32(1):524-532
pubmed: 34185147
Diagn Interv Imaging. 2020 May;101(5):299-310
pubmed: 32173289
J Bone Miner Res. 2020 Mar;35(3):446-459
pubmed: 31643098
Eur J Radiol. 2021 Apr;137:109614
pubmed: 33657475
Sci Rep. 2020 Aug 7;10(1):13394
pubmed: 32770125
Diagnostics (Basel). 2021 Nov 25;11(12):
pubmed: 34943428
J Clin Med. 2021 Dec 09;10(24):
pubmed: 34945053
Int J Cardiovasc Imaging. 2019 Apr;35(4):733-739
pubmed: 30635819
Diagn Interv Imaging. 2023 Oct;104(10):490-499
pubmed: 37248095
Nanoscale Horiz. 2022 May 3;7(5):533-542
pubmed: 35311837
Clin Transl Radiat Oncol. 2022 Jan 11;33:66-69
pubmed: 35097226
Radiology. 2022 Dec;305(3):650-652
pubmed: 35880983
Front Cardiovasc Med. 2022 Sep 06;9:981012
pubmed: 36148053
Eur Radiol. 2021 Sep;31(9):7132-7142
pubmed: 33740093
NPJ Breast Cancer. 2021 Jan 4;7(1):3
pubmed: 33398008
Invest Radiol. 2022 Dec 1;57(12):773-779
pubmed: 35640003
Sci Rep. 2019 Dec 27;9(1):19850
pubmed: 31882698
J Med Imaging (Bellingham). 2017 Oct;4(4):043502
pubmed: 29181429
J Am Coll Cardiol. 2021 Nov 30;78(22):e187-e285
pubmed: 34756653
Br J Radiol. 2014 Aug;87(1040):20130798
pubmed: 24874766
Eur Radiol. 2019 Dec;29(12):6762-6771
pubmed: 31264015
Diagn Interv Imaging. 2021 May;102(5):329-332
pubmed: 33446464
AJR Am J Roentgenol. 2012 Nov;199(5 Suppl):S3-8
pubmed: 23097165
Radiology. 2018 Oct;289(1):103-110
pubmed: 29969071
Invest Radiol. 2022 Nov 01;57(11):734-741
pubmed: 35703439
Diagnostics (Basel). 2022 Feb 22;12(3):
pubmed: 35328111
Eur Radiol. 2018 Dec;28(12):5100-5110
pubmed: 29846802
AJR Am J Roentgenol. 2018 Apr;210(4):734-741
pubmed: 29446668
Eur Radiol. 2016 Jun;26(6):1871-8
pubmed: 26373752
J Cardiovasc Comput Tomogr. 2018 Nov - Dec;12(6):509-515
pubmed: 30509378
Eur J Radiol. 2022 Jun;151:110325
pubmed: 35472649
Sci Rep. 2019 Jun 11;9(1):8458
pubmed: 31186467
Invest Radiol. 2022 Feb 1;57(2):115-121
pubmed: 34352805
Contrast Media Mol Imaging. 2018 Dec 18;2018:2136840
pubmed: 30662379
Br J Radiol. 2022 Jul 1;95(1135):20211367
pubmed: 35357902
AJNR Am J Neuroradiol. 2022 Apr;43(4):579-584
pubmed: 35332019
Eur Radiol Exp. 2022 Jul 27;6(1):31
pubmed: 35882679
Radiology. 2015 Sep;276(3):637-53
pubmed: 26302388
Invest Radiol. 2020 Feb;55(2):91-100
pubmed: 31770297
Eur J Radiol. 2023 Feb;159:110662
pubmed: 36565594
Radiol Imaging Cancer. 2022 Nov;4(6):e220073
pubmed: 36399038
Eur Heart J. 2021 Apr 7;42(14):1289-1367
pubmed: 32860058
Radiology. 2017 Jul;284(1):228-243
pubmed: 28240562
Eur Radiol. 2022 Oct;32(10):7079-7086
pubmed: 35689699
Radiology. 2016 Apr;279(1):239-45
pubmed: 26840654
Radiology. 2012 Jan;262(1):290-7
pubmed: 22084206
Eur Radiol Exp. 2022 Feb 22;6(1):10
pubmed: 35190914
Radiology. 2022 Apr;303(1):130-138
pubmed: 34904876
Radiology. 2023 Jan;306(1):229-236
pubmed: 36066364
Sci Rep. 2017 Jul 6;7(1):4784
pubmed: 28684756
Skeletal Radiol. 2023 Jan;52(1):23-29
pubmed: 35831718
Radiology. 2015 Jun;275(3):772-82
pubmed: 25742194
Eur Heart J. 2020 Jan 14;41(3):407-477
pubmed: 31504439
Phys Med Biol. 2023 Aug 14;68(17):
pubmed: 37506710
Radiographics. 2019 May-Jun;39(3):729-743
pubmed: 31059394
Invest Radiol. 2022 Apr 1;57(4):212-221
pubmed: 34711766
AJR Am J Roentgenol. 2023 Apr;220(4):551-560
pubmed: 36259593
Med Phys. 2017 Oct;44(10):5120-5127
pubmed: 28444761
Radiology. 2010 Sep;256(3):774-82
pubmed: 20668118
Med Phys. 2021 Nov;48(11):6658-6672
pubmed: 34520066
Invest Radiol. 2018 Oct;53(10):629-639
pubmed: 29794948
Angew Chem Int Ed Engl. 2010 Dec 10;49(50):9635-9
pubmed: 21077082
Radiology. 2021 Jul;300(1):98-107
pubmed: 33944628
Nanotheranostics. 2020 Apr 22;4(3):129-141
pubmed: 32483519
Eur Radiol. 2022 May;32(5):3447-3457
pubmed: 34997284
Eur Radiol. 2021 Sep;31(9):6621-6630
pubmed: 33713174
Diagnostics (Basel). 2021 Sep 18;11(9):
pubmed: 34574049
Invest Radiol. 2021 Oct 1;56(10):653-660
pubmed: 33867450
Invest Radiol. 2019 Mar;54(3):129-137
pubmed: 30461437
Invest Radiol. 2022 Jun 1;57(6):399-405
pubmed: 35025834
Insights Imaging. 2021 Sep 27;12(1):138
pubmed: 34580788
Radiol Cardiothorac Imaging. 2023 Jan 26;5(1):e220140
pubmed: 36860835
Invest Radiol. 2018 Mar;53(3):143-149
pubmed: 28945655
Invest Radiol. 2022 Dec 1;57(12):780-788
pubmed: 35640019
Radiology. 2018 Nov;289(2):293-312
pubmed: 30179101
Proc SPIE Int Soc Opt Eng. 2022 Feb-Mar;12031:
pubmed: 35574205

Auteurs

Philippe C Douek (PC)

From the University of Lyon, INSA-Lyon, Claude Bernard Lyon 1 University, UJM-Saint Etienne, CNRS, Inserm, Villeurbanne, France (P.C.D., L.B., S.A.S.M.); Department of Cardiovascular and Thoracic Radiology, Louis Pradel Hospital, Hospices Civils de Lyon, 59 Boulevard Pinel, 69500 Bron, France (P.C.D., S.B., L.B., S.A.S.M.); Claude Bernard Lyon 1 University, Villeurbanne, France (S.B.); Department of Radiology and Nuclear Medicine, Erasmus Medical Center, Rotterdam, the Netherlands (E.H.G.O., R.P.J.B.); Department of Radiology, University of Pennsylvania, Philadelphia, Pa (D.P.C.); Department of Radiology and Imaging Sciences, Emory University, Atlanta, Ga (A.P.); Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, Ga (A.P.); and Winship Cancer Institute, Atlanta, Ga (A.P.).

Sara Boccalini (S)

From the University of Lyon, INSA-Lyon, Claude Bernard Lyon 1 University, UJM-Saint Etienne, CNRS, Inserm, Villeurbanne, France (P.C.D., L.B., S.A.S.M.); Department of Cardiovascular and Thoracic Radiology, Louis Pradel Hospital, Hospices Civils de Lyon, 59 Boulevard Pinel, 69500 Bron, France (P.C.D., S.B., L.B., S.A.S.M.); Claude Bernard Lyon 1 University, Villeurbanne, France (S.B.); Department of Radiology and Nuclear Medicine, Erasmus Medical Center, Rotterdam, the Netherlands (E.H.G.O., R.P.J.B.); Department of Radiology, University of Pennsylvania, Philadelphia, Pa (D.P.C.); Department of Radiology and Imaging Sciences, Emory University, Atlanta, Ga (A.P.); Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, Ga (A.P.); and Winship Cancer Institute, Atlanta, Ga (A.P.).

Edwin H G Oei (EHG)

From the University of Lyon, INSA-Lyon, Claude Bernard Lyon 1 University, UJM-Saint Etienne, CNRS, Inserm, Villeurbanne, France (P.C.D., L.B., S.A.S.M.); Department of Cardiovascular and Thoracic Radiology, Louis Pradel Hospital, Hospices Civils de Lyon, 59 Boulevard Pinel, 69500 Bron, France (P.C.D., S.B., L.B., S.A.S.M.); Claude Bernard Lyon 1 University, Villeurbanne, France (S.B.); Department of Radiology and Nuclear Medicine, Erasmus Medical Center, Rotterdam, the Netherlands (E.H.G.O., R.P.J.B.); Department of Radiology, University of Pennsylvania, Philadelphia, Pa (D.P.C.); Department of Radiology and Imaging Sciences, Emory University, Atlanta, Ga (A.P.); Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, Ga (A.P.); and Winship Cancer Institute, Atlanta, Ga (A.P.).

David P Cormode (DP)

From the University of Lyon, INSA-Lyon, Claude Bernard Lyon 1 University, UJM-Saint Etienne, CNRS, Inserm, Villeurbanne, France (P.C.D., L.B., S.A.S.M.); Department of Cardiovascular and Thoracic Radiology, Louis Pradel Hospital, Hospices Civils de Lyon, 59 Boulevard Pinel, 69500 Bron, France (P.C.D., S.B., L.B., S.A.S.M.); Claude Bernard Lyon 1 University, Villeurbanne, France (S.B.); Department of Radiology and Nuclear Medicine, Erasmus Medical Center, Rotterdam, the Netherlands (E.H.G.O., R.P.J.B.); Department of Radiology, University of Pennsylvania, Philadelphia, Pa (D.P.C.); Department of Radiology and Imaging Sciences, Emory University, Atlanta, Ga (A.P.); Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, Ga (A.P.); and Winship Cancer Institute, Atlanta, Ga (A.P.).

Amir Pourmorteza (A)

From the University of Lyon, INSA-Lyon, Claude Bernard Lyon 1 University, UJM-Saint Etienne, CNRS, Inserm, Villeurbanne, France (P.C.D., L.B., S.A.S.M.); Department of Cardiovascular and Thoracic Radiology, Louis Pradel Hospital, Hospices Civils de Lyon, 59 Boulevard Pinel, 69500 Bron, France (P.C.D., S.B., L.B., S.A.S.M.); Claude Bernard Lyon 1 University, Villeurbanne, France (S.B.); Department of Radiology and Nuclear Medicine, Erasmus Medical Center, Rotterdam, the Netherlands (E.H.G.O., R.P.J.B.); Department of Radiology, University of Pennsylvania, Philadelphia, Pa (D.P.C.); Department of Radiology and Imaging Sciences, Emory University, Atlanta, Ga (A.P.); Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, Ga (A.P.); and Winship Cancer Institute, Atlanta, Ga (A.P.).

Loic Boussel (L)

From the University of Lyon, INSA-Lyon, Claude Bernard Lyon 1 University, UJM-Saint Etienne, CNRS, Inserm, Villeurbanne, France (P.C.D., L.B., S.A.S.M.); Department of Cardiovascular and Thoracic Radiology, Louis Pradel Hospital, Hospices Civils de Lyon, 59 Boulevard Pinel, 69500 Bron, France (P.C.D., S.B., L.B., S.A.S.M.); Claude Bernard Lyon 1 University, Villeurbanne, France (S.B.); Department of Radiology and Nuclear Medicine, Erasmus Medical Center, Rotterdam, the Netherlands (E.H.G.O., R.P.J.B.); Department of Radiology, University of Pennsylvania, Philadelphia, Pa (D.P.C.); Department of Radiology and Imaging Sciences, Emory University, Atlanta, Ga (A.P.); Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, Ga (A.P.); and Winship Cancer Institute, Atlanta, Ga (A.P.).

Salim A Si-Mohamed (SA)

From the University of Lyon, INSA-Lyon, Claude Bernard Lyon 1 University, UJM-Saint Etienne, CNRS, Inserm, Villeurbanne, France (P.C.D., L.B., S.A.S.M.); Department of Cardiovascular and Thoracic Radiology, Louis Pradel Hospital, Hospices Civils de Lyon, 59 Boulevard Pinel, 69500 Bron, France (P.C.D., S.B., L.B., S.A.S.M.); Claude Bernard Lyon 1 University, Villeurbanne, France (S.B.); Department of Radiology and Nuclear Medicine, Erasmus Medical Center, Rotterdam, the Netherlands (E.H.G.O., R.P.J.B.); Department of Radiology, University of Pennsylvania, Philadelphia, Pa (D.P.C.); Department of Radiology and Imaging Sciences, Emory University, Atlanta, Ga (A.P.); Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, Ga (A.P.); and Winship Cancer Institute, Atlanta, Ga (A.P.).

Ricardo P J Budde (RPJ)

From the University of Lyon, INSA-Lyon, Claude Bernard Lyon 1 University, UJM-Saint Etienne, CNRS, Inserm, Villeurbanne, France (P.C.D., L.B., S.A.S.M.); Department of Cardiovascular and Thoracic Radiology, Louis Pradel Hospital, Hospices Civils de Lyon, 59 Boulevard Pinel, 69500 Bron, France (P.C.D., S.B., L.B., S.A.S.M.); Claude Bernard Lyon 1 University, Villeurbanne, France (S.B.); Department of Radiology and Nuclear Medicine, Erasmus Medical Center, Rotterdam, the Netherlands (E.H.G.O., R.P.J.B.); Department of Radiology, University of Pennsylvania, Philadelphia, Pa (D.P.C.); Department of Radiology and Imaging Sciences, Emory University, Atlanta, Ga (A.P.); Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, Ga (A.P.); and Winship Cancer Institute, Atlanta, Ga (A.P.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH